Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1)

Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1)

US Patent 11332531 · Granted May 17, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Kit for early screening of liver cell cancer and preparation method and use ther2025
Pixel output settling assist with dynamic bias current2025
Pixel output parasitic capacitance reduction and predictive settling assist2024
Method of ctDNA library construction and sequencing data analysis for simultaneo2024
Directing treatments for glioblastoma based on identifying a somatic structural 2023
Calcitonin gene-related peptide (CGRP) antagonist antibodies2023
Calcitonin gene-related peptide (CGRP) antagonist antibodies2023
Methods for treating heart failure using glucagon receptor antagonistic antibodi2022
Methods for treating type 1 diabetes using glucagon receptor antagonistic antibo2022
Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CT2022
Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CT2022
Combination of glucagon receptor antagonists and PI3K pathway inhibitors for the2022